Haemonetics | HAE - Przychody Ze Sprzedaży





Obroty Zmiana Data
Avanos Medical USD 180.9M 3.1M 2025-12
Baxter International USD 2.97B 130M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Boston Scientific USD 5.29B 220M 2025-12
Cerus USD 50.81M 4.79M 2024-12
Cooper Companies USD 1.02B 41.1M 2025-12
Fresenius EUR 5.88B 400M 2025-12
Fresenius Medical Care EUR 5.07B 180M 2025-12
Globus Medical USD 826.4M 57.4M 2025-12
Haemonetics USD 338.97M 11.97M 2025-12
Hologic USD 1.05B 0 2025-12
ICU Medical USD 540.7M 3.7M 2025-12
Intuitive Surgical USD 2.87B 360M 2025-12
Masimo USD 412.5M 41M 2025-12
Medtronic USD 9B 39M 2026-01
Merit Medical Systems USD 393.9M 9.7M 2025-12
Neogen USD 224.69M 15.5M 2025-09
OraSure Technologies USD 26.76M 322K 2025-12
Plus Therapeutics USD 1.37M 30K 2025-12
Quidel USD 724M 24M 2025-12
ResMed USD 1.4B 100M 2025-12
STAAR Surgical USD 239.4M 144.7M 2025-12
Steris USD 1.5B 470M 2025-12
Stryker USD 7.2B 1.14B 2025-12
Surmodics USD 29.57M 355K 2025-06
Teleflex USD 568.98M 344.02M 2025-12
Terumo JPY 296.63B 21.66B 2025-12
Thermo Fisher Scientific USD 12.21B 1.09B 2025-12
US Physical Therapy USD 202.73M 5.6M 2025-12
Zimmer Biomet Holdings USD 2.24B 240M 2025-12